Abiopharma

New Form 424B3 - SOLIGENIX, INC. Filed: 2025-08-15 AccNo: 0001558370-25-011617 Size: 1 MB

Broderick Christopher adjusted position in 0 shares of ATLANTIC INTERNATIONAL CORP. (ATLN) Filed: 2025-08-15 AccNo: 0001213900-25-077567 Size: 5 KB

Dreyer Scott adjusted position in 0.0 shares of COLLEGIUM PHARMACEUTICAL, INC (COLL) at average price $38.03 Filed: 2025-08-15 AccNo: 0001062993-25-014526 Size: 8 KB

New Form 8-K - Entero Therapeutics, Inc. Filed: 2025-08-15 AccNo: 0001104659-25-079322 Size: 250 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form DEF 14A - ProPhase Labs, Inc. Filed: 2025-08-15 AccNo: 0001641172-25-024375 Size: 1 MB

New Form 10-K - BIOVIE INC. Filed: 2025-08-15 AccNo: 0001520138-25-000268 Size: 5 MB

Director Koenig Scott acquired 52.8k shares of MACROGENICS INC (MGNX) Filed: 2025-08-15 AccNo: 0001587514-25-000005 Size: 10 KB

Guardant Health, Inc. - Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 8-K - Innovative Eyewear Inc Filed: 2025-08-15 AccNo: 0001829126-25-006385 Size: 261 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Director Risser Eric Blasius adjusted position in 0 shares of MACROGENICS INC (MGNX) Filed: 2025-08-15 AccNo: 0001587774-25-000004 Size: 5 KB

New Form PREM14A - ZimVie Inc. Filed: 2025-08-15 AccNo: 0001193125-25-181940 Size: 2 MB

New Form NT 10-Q - Agentix Corp. Filed: 2025-08-15 AccNo: 0001477932-25-005988 Size: 20 KB

New Form 144 - Doximity, Inc. Filed: 2025-08-15 AccNo: 0001950047-25-005938 Size: 6 KB

New Form 144 - DEXCOM INC Filed: 2025-08-15 AccNo: 0001950047-25-005937 Size: 6 KB